NCT00181922View on ClinicalTrials.gov

Ziprasidone for the Treatment of Mania in Children and Adolescents With Bipolar Disorder

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 31, 2002

Study Completion Date

December 31, 2004

Conditions
Bipolar DisorderMania
Interventions
DRUG

ziprasidone (Geodon)

Trial Locations (2)

02114

Massachusetts General Hospital, Boston

02138

Massachusetts General Hospital, Cambridge

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Massachusetts General Hospital

OTHER

NCT00181922 - Ziprasidone for the Treatment of Mania in Children and Adolescents With Bipolar Disorder | Biotech Hunter | Biotech Hunter